• OPEN AN ACCOUNT
Indian Indices
Sensex
72,771.72 -1,124.02
( -1.52%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,234.37 -129.83
(-0.20%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

USFDA concludes inspection of Wanbury's facility at Tanuku, Andhra Pradesh
Jul 21,2026
Wanbury announced that a routine current Good Manufacturing Practices ( cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the company's facility at Tanuku, West Godavari District, Andhra Pradesh during the period from 13 July 2026 to 17 July 2026.

At the conclusion of the inspection, the U.S.FDA has issued a Form 483 with six observations. The Company will respond to these observations to FDA within the stipulated time.